Prakken A B, van Eden W, Rijkers G T, Kuis W, Toebes E A, de Graeff-Meeder E R, van der Zee R, Zegers B J
University Hospital for Children and Youth, Het Wilhelmina Kinderziekenhuis, Department of Immunology, Utrecht, The Netherlands.
Arthritis Rheum. 1996 Nov;39(11):1826-32. doi: 10.1002/art.1780391108.
To determine whether T lymphocyte reactivity to endogenous human hsp60 plays a regulatory role in the course of oligoarticular juvenile rheumatoid arthritis (JRA).
A prospective, longitudinal study of T cell reactivity to HSP in 15 patients with newly diagnosed HLA-B27 negative oligoarticular JRA was performed. Results were compared with those in a group of 20 patients with newly diagnosed polyarticular or systemic JRA or with acute arthritis caused by other systemic diseases or viral infections, as well as with those in a group of 9 healthy control subjects.
In 86% of the patients with oligoarticular JRA (13 of 15), significant T lymphocyte proliferative responses to hsp60 were found in peripheral blood mononuclear cells and/or synovial fluid mononuclear cells within 3 months after the onset of arthritis. Only 5% of the patients in the rheumatologic disease control group (1 of 20) showed such positivity. All patients with oligoarticular JRA and positive responses to human hsp60 developed a remission of their disease within 12 weeks. During this period of remission, blood samples were taken from 8 patients and showed significantly lower and even negative responses to hsp60, compared with active disease, when all 8 patients had good responses.
The results show that significant proliferative responses to human hsp60 can be found early in the course of oligoarticular JRA. Furthermore, these responses correlate with disease activity in such a manner that T cell reactivity to human hsp60 seems to be associated with disease remission.
确定T淋巴细胞对内源性人类热休克蛋白60(hsp60)的反应性在少关节型幼年类风湿关节炎(JRA)病程中是否发挥调节作用。
对15例新诊断的HLA - B27阴性少关节型JRA患者的T细胞对热休克蛋白(HSP)的反应性进行了一项前瞻性纵向研究。将结果与20例新诊断的多关节型或全身型JRA患者或由其他全身性疾病或病毒感染引起的急性关节炎患者组以及9例健康对照受试者组的结果进行比较。
在少关节型JRA患者中,86%(15例中的13例)在关节炎发作后3个月内,外周血单核细胞和/或滑液单核细胞中发现对hsp60有显著的T淋巴细胞增殖反应。风湿性疾病对照组中只有5%(20例中的1例)的患者表现出这种阳性反应。所有对人类hsp60有阳性反应的少关节型JRA患者在12周内病情缓解。在缓解期,从8例患者采集血样,与疾病活动期相比,当所有8例患者反应良好时,对hsp60的反应显著降低甚至呈阴性。
结果表明,在少关节型JRA病程早期可发现对人类hsp60的显著增殖反应。此外,这些反应与疾病活动相关,以至于T细胞对人类hsp60的反应性似乎与疾病缓解有关。